A randomized, controlled trial of surgery for temporal-lobe epilepsy

New England Journal of Medicine

Volumn 345, Issue 5, 2001, Pages 311-318

  Wiebe, Smauel ^a,b   Blume, Warren T ^a,b   Girvin, John P ^a,b   Eliasziw, Michael ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MORALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TEMPORAL LOBE EPILEPSY; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; DISEASE-FREE SURVIVAL; EMPLOYMENT; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; MALE; NEUROSURGERY; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; TEMPORAL LOBE; TREATMENT OUTCOME;

EID: 0035797593     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200108023450501     Document Type: Article

References (40)

1. Incidence and prevalence
2. Burden of epilepsy: The Ontario Health Survey
3. The global burden of disease in 1990: Summary results, sensitivity analysis and future directions
4. Bringing epilepsy out of the shadows
5. Hughlings Jackson's Dr. Z: The paradigm of temporal lobe epilepsy revealed
6. The timing of surgical intervention for mesial temporal lobe epilepsy: A plan for a randomized clinical trial
7. Is the underlying cause of epilepsy a major prognostic factor for recurrence?
8. Temporal lobectomy for refractory epilepsy
9. Overview: Who should be considered a surgical candidate?
10. Surgery for epilepsy
11. Outcome with respect to epileptic seizures
12. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
13. The unpredictability paradox: Review of empirical comparisons of randomised and non-randomised clinical trials
14. Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery
15. Health-related quality of life and seizure control in temporal lobe epilepsy
16. Amygdalar sclerosis: Preoperative indicators and outcome after temporal lobectomy
17. Proposal for revised classification of epilepsies and epileptic syndromes
18. Multiple electrodes for detecting spikes in partial complex seizures
19. Interictal indices of temporal seizure origin
20. Effectiveness of temporal lobectomy measured by yearly follow-up and multivariate analysis
21. Principles of clinical investigation of surgical patients
22. Resection of intracranial lesions under local anesthesia
23. Antiepileptic drugs
24. Quality of life in epilepsy: The Liverpool initiative
25. Assessing quality of life in epilepsy: Development of a new inventory
26. A scaled version of the General Health Questionnaire
27. The CES-D scale: A self-report depression scale for research in the general population
28. An economic evaluation of surgery for temporal lobe epilepsy
29. In search of a minimum clinically important change in epilepsy specific quality of life instruments
30. Seizure outcome after temporal lobectomy for temporal lobe epilepsy: A Kaplan-Meier survival analysis
31. Improvement and deterioration of seizure control during the postsurgical course of epilepsy surgery patients
32. Longitudinal follow-up in 145 patients with medically refractory temporal lobe epilepsy treated surgically between 1984 and 1995
33. Assessing changes over time in temporal lobectomy: Outcome by scoring seizure frequency
34. Temporal lobectomy for partial complex seizures: Evaluation, results, and 1-year follow-up
35. Anterior temporal lobectomy for complex partial seizures: Evaluation, results, and long-term follow-up in 100 cases
36. Complications of epilepsy surgery
37. Early identification of refractory epilepsy
38. Epilepsy brain surgery: A Pittsburgh perspective
39. When is imaging enough?
40. Five-year outcome after epilepsy surgery in nonmonitored and monitored surgical candidates